Global Pre-Clinical Imaging (In Vivo) Market worth $1.55 Bn By 2017

Tuesday 11 December 2012, Amsterdam

The report "Global Pre-clinical Imaging (In vivo) Market By systems and reagents (Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT Multimodality/Hybrid Imaging Modalities) - Competitive Analysis Global Forecasts to 2017"- analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

This report studies the global pre-clinical imaging (in vivo) market over the forecast period of 2012-2017.

The global pre-clinical imaging (in vivo) market is broadly segmented into two categories, namely, imaging systems and imaging reagents, and is expected to grow at a CAGR of 14.5% from 2012 to 2017. Imaging systems can be divided into standalone imaging systems and multimodal imaging systems. Standalone imaging systems are further classified into nuclear imaging, optical imaging, Micro-MRI, Micro-CT and Micro-Ultrasound. Multimodal imaging systems are classified into multimodal nuclear imaging devices and multimodal optical imaging devices. Imaging reagents can be divided into nuclear imaging agents, optical imaging agents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents.

The global pre-clinical imaging (in vivo) market has witnessed challenging and dynamic market conditions over the last couple of years, and is valued at $789.4 million in 2012 with an estimated annual growth rate of 14.5% over the next five years. Pre-clinical in vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the global over the past decade. It is expected that the trend of product development and modification will continue in future to solve the present challenges and unmet needs of the market. Market displays growing preference for hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. The global pre-clinical imaging (in vivo) market is expected to show growth over the long term due to driving factors such as technological advancements, growing adoption rate for pre-clinical imaging, rising application of functional imaging and increasing number of pharma companies and research institutions.